Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 09, 2024

BUY
$0.65 - $1.25 $19,836 - $38,147
30,518 New
30,518 $25,000
Q2 2022

Aug 12, 2022

SELL
$1.35 - $2.29 $11,040 - $18,727
-8,178 Reduced 28.0%
21,030 $44,000
Q1 2022

May 16, 2022

BUY
$1.46 - $2.45 $42,643 - $71,559
29,208 New
29,208 $60,000
Q3 2021

Nov 15, 2021

SELL
$3.14 - $3.9 $272,869 - $338,913
-86,901 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$3.8 - $4.56 $210,599 - $252,719
55,421 Added 176.05%
86,901 $337,000
Q1 2021

May 17, 2021

BUY
$4.33 - $6.63 $11,842 - $18,133
2,735 Added 9.51%
31,480 $144,000
Q4 2020

Feb 16, 2021

BUY
$4.87 - $17.29 $139,988 - $497,001
28,745 New
28,745 $173,000

Others Institutions Holding ASMB

# of Institutions
1
Shares Held
16.3K
Call Options Held
0
Put Options Held
0

About ASSEMBLY BIOSCIENCES, INC.


  • Ticker ASMB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,436,900
  • Market Cap $737M
  • Description
  • Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also deve...
More about ASMB
Track This Portfolio

Track Hrt Financial LP Portfolio

Follow Hrt Financial LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Hrt Financial LP with notifications on news.